Law360, New York (April 24, 2012, 8:25 PM EDT) -- A federal judge refused Tuesday to ask six state high courts to decide whether Eli Lilly & Co. and Xanodyne Pharmaceuticals Inc. could be liable for negligent representation in multidistrict litigation even when plaintiffs took generic equivalents of their painkillers Darvocet and Darvon.
In an order Tuesday, Judge Danny C. Reeves of Kentucky federal court ruled that a potentially lengthy certification process to determine the name-brand liability question would not serve the interests of resolving the MDL promptly.
The MDL arose from heart-related injuries the plaintiffs...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.